Lisa Zimmerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lisa Zimmerman has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Barend Heeren
REshape Innovation Center, Radboud University Medical Center, Nijmegen, Netherlands
2 shared publications - Cornelis J. Tack
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications - Daniele De Massari
Stryker 325 Corporate Dr 07430 Mahwah NJ
2 shared publications - Gerardus J Lancee
Radboud REshape Innovation Center Radboud University Medical Center Nijmegen Netherlands
2 shared publications - Lucien Jlpg Engelen
Radboud University Medical Center, Radboud REshape Innovation Center, Nijmegen, Netherlands
2 shared publications - Marleen M. H. J. van Gelder
IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 23 November 2018
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 3 (4) , e17
Glucose Control, Disease Burden, and Educational Gaps in People With Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App
Emerging Technologies, Medical Devices, Apps, Sensors, and Informatics to Help People with Diabetes
- 23 November 2018
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 3 (4) , e17
Open AccessGlucose Control, Disease Burden, and Educational Gaps in People With Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App
Emerging Technologies, Medical Devices, Apps, Sensors, and Informatics to Help People with Diabetes
- Open Access
- 30 November 2017
- Published by JMIR Publications Inc. in JMIR Preprints
Glucose Control, Disease Burden, and Educational Gaps in People With Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App (Preprint)
BACKGROUND Self-monitoring and self-management, crucial for optimal glucose control in type 1 diabetes, requires many disease-related decisions per day and imposes a substantial disease burden on people with diabetes. Innovative technologies that integrate relevant measurements may offer solutions that support self-management, decrease disease burden, and benefit diabetes control. OBJECTIVE The objective of our study was to evaluate a prototype integrated mobile phone diabetes app in people with type 1 diabetes. METHODS In this exploratory study, we developed an app that contained cloud-stored log functions for glucose, carbohydrates (including a library), insulin, planned exercise, and mood, combined with a bolus calculator and communication functions. Adults with diabetes tested the app for 6 weeks. We assessed the feasibility of app use, user experiences, perceived disease burden (through questionnaires), insulin dose and basal to bolus ratio, mean glucose level, hemoglobin A1c, and number of hypoglycemic events. RESULTS A total of 19 participants completed the study, resulting in 5782 data entries. The most frequently used feature was logging blood glucose, insulin, and carbohydrates. Mean diabetes-related emotional problems (measured with the Problem Areas in Diabetes scale) scores decreased from 14.4 (SD 10.0) to 12.2 (SD 10.3; P=.04), and glucose control improved, with hemoglobin A1c decreasing from 7.9% (mean 62.3, SD 8 mmol/mol) to 7.6% (mean 59.8, SD 7 mmol/mol; P=.047). The incidence of hypoglycemic events did not change. Participants were generally positive about the app, rating it as “refreshing,” and as providing structure by reinforcing insulin-dosing principles. The app revealed substantial knowledge gaps. Logged data enabled additional detailed analyses. CONCLUSIONS An integrated mobile diabetes app has the potential to improve diabetes self-management and provide tailored educational support, which may decrease disease burden and benefit diabetes control.
- 30 November 2017
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessGlucose Control, Disease Burden, and Educational Gaps in People With Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App (Preprint)
BACKGROUND Self-monitoring and self-management, crucial for optimal glucose control in type 1 diabetes, requires many disease-related decisions per day and imposes a substantial disease burden on people with diabetes. Innovative technologies that integrate relevant measurements may offer solutions that support self-management, decrease disease burden, and benefit diabetes control. OBJECTIVE The objective of our study was to evaluate a prototype integrated mobile phone diabetes app in people with type 1 diabetes. METHODS In this exploratory study, we developed an app that contained cloud-stored log functions for glucose, carbohydrates (including a library), insulin, planned exercise, and mood, combined with a bolus calculator and communication functions. Adults with diabetes tested the app for 6 weeks. We assessed the feasibility of app use, user experiences, perceived disease burden (through questionnaires), insulin dose and basal to bolus ratio, mean glucose level, hemoglobin A1c, and number of hypoglycemic events. RESULTS A total of 19 participants completed the study, resulting in 5782 data entries. The most frequently used feature was logging blood glucose, insulin, and carbohydrates. Mean diabetes-related emotional problems (measured with the Problem Areas in Diabetes scale) scores decreased from 14.4 (SD 10.0) to 12.2 (SD 10.3; P=.04), and glucose control improved, with hemoglobin A1c decreasing from 7.9% (mean 62.3, SD 8 mmol/mol) to 7.6% (mean 59.8, SD 7 mmol/mol; P=.047). The incidence of hypoglycemic events did not change. Participants were generally positive about the app, rating it as “refreshing,” and as providing structure by reinforcing insulin-dosing principles. The app revealed substantial knowledge gaps. Logged data enabled additional detailed analyses. CONCLUSIONS An integrated mobile diabetes app has the potential to improve diabetes self-management and provide tailored educational support, which may decrease disease burden and benefit diabetes control.
- 6 August 2005
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 4 (5) , 1672-1680
Identification of Protein Fragments as Pattern Features in MALDI−MS Analyses of Serum
The use of matrix-assisted laser desorption ionization mass spectrometry (MALDI−MS) to acquire spectral profiles has become a common approach to detect proteomic biomarkers of disease. MALDI−MS signals may represent both intact proteins as well as proteolysis products. Liquid chromatography-tandem mass spectrometry (LC−MS/MS) analysis can tentatively identify the corresponding proteins Here, we describe the application of a data analysis utility called FragMint, which combines MALDI−MS spectral data with LC−MS/MS based protein identifications to generate candidate protein fragments consistent with both types of data. This approach was used to identify protein fragments corresponding to spectral signals in MALDI−MS analyses of unfractionated human serum. The serum also was analyzed by one-dimensional SDS-PAGE and bands corresponding to the MALDI−MS signal masses were excised and subjected to in-gel digestion and LC−MS/MS analysis. Database searches mapped all of the identified peptides to abundant blood proteins larger than the observed MALDI−MS signals. FragMint identified fragments of these proteins that contained the MS/MS identified sequences and were consistent with the observed MALDI−MS signals. This approach should be generally applicable to identify protein species corresponding to MALDI−MS signals. Keywords: serum • MALDI • LC−MS/MS • bioinformatics • proteolysis
- 6 August 2005
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 4 (5) , 1672-1680
Identification of Protein Fragments as Pattern Features in MALDI−MS Analyses of Serum
The use of matrix-assisted laser desorption ionization mass spectrometry (MALDI−MS) to acquire spectral profiles has become a common approach to detect proteomic biomarkers of disease. MALDI−MS signals may represent both intact proteins as well as proteolysis products. Liquid chromatography-tandem mass spectrometry (LC−MS/MS) analysis can tentatively identify the corresponding proteins Here, we describe the application of a data analysis utility called FragMint, which combines MALDI−MS spectral data with LC−MS/MS based protein identifications to generate candidate protein fragments consistent with both types of data. This approach was used to identify protein fragments corresponding to spectral signals in MALDI−MS analyses of unfractionated human serum. The serum also was analyzed by one-dimensional SDS-PAGE and bands corresponding to the MALDI−MS signal masses were excised and subjected to in-gel digestion and LC−MS/MS analysis. Database searches mapped all of the identified peptides to abundant blood proteins larger than the observed MALDI−MS signals. FragMint identified fragments of these proteins that contained the MS/MS identified sequences and were consistent with the observed MALDI−MS signals. This approach should be generally applicable to identify protein species corresponding to MALDI−MS signals. Keywords: serum • MALDI • LC−MS/MS • bioinformatics • proteolysis